Shared Vision Wealth Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$228K Hold
248
0.09% 89
2025
Q4
$263K Buy
248
+1
+0.4% +$956 0.11% 86
2025
Q3
$201K Buy
+247
New +$184K 0.09% 98
2025
Q2
Sell
-246
Closed -$204K 86
2025
Q1
$204K Buy
+246
New +$205K 0.11% 78
2024
Q4
Sell
-246
Closed -$218K 77
2024
Q3
$218K Buy
246
+1
+0.4% +$899 0.12% 71
2024
Q2
$222K Buy
+245
New +$196K 0.13% 72

Other funds holding LLY

Shared Vision Wealth Group's LLY Position: Q1 2026 in Review

Shared Vision Wealth Group held its Eli Lilly (LLY) position steady in Q1 2026 at 248 shares worth $228K. The position accounts for 0.09% of the portfolio, ranked #89.

Shared Vision Wealth Group first reported a position in LLY in Q2 2024 and has held it in 6 quarters since. The position peaked at $263K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Shared Vision Wealth Group held 248 shares of Eli Lilly worth $228K as of Q1 2026.
  • Shared Vision Wealth Group left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.09% of Shared Vision Wealth Group's portfolio in Q1 2026, its #89 holding.
  • Shared Vision Wealth Group first reported a position in Eli Lilly in Q2 2024 and has held it in 6 quarters since.
  • Shared Vision Wealth Group's Eli Lilly position peaked at $263K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Shared Vision Wealth Group's 13F filing for Q1 2026, filed 6 May 2026.